p.33 抽出テキスト

Arnett et al 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

September 10, 2019 Circulation. 2019;140:e596–e646. DOI: 10.1161/CIR.0000000000000678 e628

CLINICAL STATEMENTS AND GUIDELINES S3.1-4. Satija A, Bhupathiraju SN, Spiegelman D, et al. Healthful and unhealthful plant-based diets and the risk of coronary heart disease in US adults. J Am Coll Cardiol. 2017;70:411–22. S3.1-5. Sotos-Prieto M, Bhupathiraju SN, Mattei J, et al. Association of changes in diet quality with total and cause-specific mortality. N Engl J Med. 2017;377:143–53. S3.1-6. Whalen KA, Judd S, McCullough ML, et al. Paleolithic and Mediterranean diet pattern scores are inversely associated with allcause and cause-specific mortality in adults. J Nutr. 2017;147:612–20. S3.1-7. Bao Y, Han J, Hu FB, et al. Association of nut consumption with total and cause-specific mortality. N Engl J Med. 2013;369:2001–11. S3.1-8. Bernstein AM, Sun Q, Hu FB, et al. Major dietary protein sources and risk of coronary heart disease in women. Circulation. 2010;122:876–83. S3.1-9. Song M, Fung TT, Hu FB, et al. Association of animal and plant protein intake with all-cause and cause-specific mortality. JAMA Intern Med. 2016;176:1453–63. S3.1-10.	 Tharrey M, Mariotti F, Mashchak A, et al. Patterns of plant and

animal protein intake are strongly associated with cardiovascular mortality: the Adventist Health Study-2 cohort. Int J Epidemiol. 2018;47:1603–12. S3.1-11.	 Martínez-González MA, Sánchez-Tainta A, Corella D, et al. A provegetarian food pattern and reduction in total mortality in the Prevención con Dieta Mediterránea (PREDIMED) study. Am J Clin Nutr 100 suppl 1 2014:320S–28S. S3.1-12.	 Wang DD, Li Y, Chiuve SE, et al. Association of specific dietary fats with total and cause-specific mortality. JAMA Intern Med. 2016;176:1134–45. S3.1-13.	 Dehghan M, Mente A, Zhang X, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. Lancet. 2017;390:2050–62. S3.1-14.	 Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3–10. S3.1-15.	 Cook NR, Cutler JA, Obarzanek E, et al. Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ. 2007;334:885–8. S3.1-16.	 Micha R, Peñalvo JL, Cudhea F, et al. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA. 2017;317:912–24. S3.1-17.	 Kiage JN, Merrill PD, Robinson CJ, et al. Intake of trans fat and allcause mortality in the Reasons for Geographical and Racial Differences in Stroke (REGARDS) cohort. Am J Clin Nutr. 2013;97:1121–8. S3.1-18.	 Löfvenborg JE, Andersson T, Carlsson P-O, et al. Sweetened beverage intake and risk of latent autoimmune diabetes in adults (LADA) and type 2 diabetes. Eur J Endocrinol. 2016;175:605–14. S3.1-19.	 Yang Q, Zhang Z, Gregg EW, et al. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med. 2014;174:516–24. S3.1-20.	 Johnson RK, Lichtenstein AH, Anderson CAM, et al. Lowcalorie sweetened beverages and cardiometabolic health: a science advisory from the American Heart Association. Circulation. 2018;138:e126–40. S3.1-21.	 Shikany JM, Safford MM, Newby PK, et al. Southern dietary pattern is associated with hazard of acute coronary heart disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) study. Circulation. 2015;132:804–14. S3.1-22.	 Seidelmann SB, Claggett B, Cheng S, et al. Dietary carbohydrate intake and mortality: a prospective cohort study and meta-analysis. Lancet Public Health. 2018;3:e419–28. S3.1-23.	 Trichopoulou A, Psaltopoulou T, Orfanos P, et al. Low-carbohydratehigh-protein diet and long-term survival in a general population cohort. Eur J Clin Nutr. 2007;61:575–81. S3.1-24.	 Noto H, Goto A, Tsujimoto T, et al. Low-carbohydrate diets and allcause mortality: a systematic review and meta-analysis of observational studies. PLoS ONE. 2013;8:e55030. S3.1-25.	 Brandt EJ, Myerson R, Perraillon MC, et al. Hospital admissions for myocardial infarction and stroke before and after the trans-fatty acid restrictions in New York. JAMA Cardiol. 2017;2:627–34. S3.1-26.	 Micha R, Mozaffarian D. Trans fatty acids: effects on meta-

bolic syndrome, heart disease and diabetes. Nat Rev Endocrinol. 2009;5:335–44. S3.1-27.	 Mozaffarian D. Dietary and policy priorities for cardiovascular dis-

ease, diabetes, and obesity: a comprehensive review. Circulation. 2016;133:187–225. S3.1-28.	 Weir HK, Anderson RN, Coleman King SM, et al. Heart disease and cancer deaths—trends and projections in the United States, 1969– 2020. Prev Chronic Dis. 2016;13:E157. S3.1-28a.	 Micha R, Wallace SK, Mozaffarian D. Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation. 2010;121:2271–83. S3.1-29.	 Van Horn L, Carson JAS, Appel LJ, et al. Recommended dietary pattern to achieve adherence to the American Heart Association/ American College of Cardiology (AHA/ACC) guidelines: a scientific statement from the American Heart Association. Circulation. 2016;134:e505–29. S3.1-30.	 Rimm EB, Appel LJ, Chiuve SE, et al. Seafood long-chain n-3 polyunsaturated fatty acids and cardiovascular disease: a science advisory from the American Heart Association. Circulation. 2018;138:e35–47. S3.1-31.	 Dehghan M, Mente A, Rangarajan S, et al. Association of dairy

intake with cardiovascular disease and mortality in 21 countries from five continents (PURE): a prospective cohort study. Lancet. 2018;392:2288–97.

3.2 Exercise and Physical Activity

S3.2-1.	 Orrow G, Kinmonth A-L, Sanderson S, et al. Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials. BMJ. 2012;344:e1389. S3.2-2.	 Sanchez A, Bully P, Martinez C, et al. Effectiveness of physical activity promotion interventions in primary care: a review of reviews. Prev Med 76 suppl 2015:S56–67. S3.2-3.	 Ekelund U, Steene-Johannessen J, Brown WJ, et al. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet. 2016;388: 1302–10. S3.2-4.	 Hamer M, Chida Y. Walking and primary prevention: a metaanalysis of prospective cohort studies. Br J Sports Med. 2008;42: 238–43. S3.2-5.	 Kyu HH, Bachman VF, Alexander LT, et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. BMJ. 2016;354:i3857. S3.2-6.	 Sattelmair J, Pertman J, Ding EL, et al. Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation. 2011;124:789–95. S3.2-7.	 Zheng H, Orsini N, Amin J, et al. Quantifying the dose-response of walking in reducing coronary heart disease risk: meta-analysis. Eur J Epidemiol. 2009;24:181–92. S3.2-8.	 Wahid A, Manek N, Nichols M, et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis. J Am Heart Assoc. 2016;5:e002495. S3.2-9.	 Biswas A, Oh PI, Faulkner GE, et al. Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med. 2015;162:123–32. S3.2-10.	 Chomistek AK, Manson JE, Stefanick ML, et al. Relationship of sedentary behavior and physical activity to incident cardiovascular disease: results from the Women’s Health Initiative. J Am Coll Cardiol. 2013;61:2346–54. S3.2-11.	 Patterson R, McNamara E, Tainio M, et al. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis. Eur J Epidemiol. 2018;33:811–29. S3.2-12.	 2018 Physical Activity Guidelines Advisory Committee. 2018 Physical Activity Guidelines Advisory Committee Scientific Report. Washington, DC: US Department of Health and Human Services, 2018. Available at: https://health.gov/paguidelines/second-edition/ report. Accessed January 3, 2019. S3.2-13.	 Lee I-M, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on

major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380:219–29.

Downloaded from http://ahajournals.org by on October 7, 2026